These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6101296)

  • 1. Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy.
    McKenna WJ; Chetty S; Oakley CM; Goodwin JF
    Am J Cardiol; 1980 Jan; 45(1):1-5. PubMed ID: 6101296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
    Maron BJ; Savage DD; Wolfson JK; Epstein SE
    Am J Cardiol; 1981 Aug; 48(2):252-7. PubMed ID: 7196685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
    McKenna WJ; England D; Doi YL; Deanfield JE; Oakley C; Goodwin JF
    Br Heart J; 1981 Aug; 46(2):168-72. PubMed ID: 7196768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmia and prognosis in hypertrophic cardiomyopathy.
    McKenna WJ
    Eur Heart J; 1983 Nov; 4 Suppl F():225-34. PubMed ID: 6686539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Savage DD; Seides SF; Maron BJ; Myers DJ; Epstein SE
    Circulation; 1979 May; 59(5):866-75. PubMed ID: 154981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia.
    Hirsowitz G; Podrid PJ; Lampert S; Stein J; Lown B
    Am Heart J; 1986 May; 111(5):852-60. PubMed ID: 2871739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambulatory ECG in cardiomyopathies].
    Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of arrhythmias in hypertrophic cardiomyopathy: role of ambulatory monitoring and signal-averaged electrocardiography.
    Gavaghan TP; Kelly RP; Kuchar DL; Hickie JB; Campbell TJ
    Aust N Z J Med; 1986 Oct; 16(5):666-70. PubMed ID: 3469964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.
    Kowey PR; Eisenberg R; Engel TR
    N Engl J Med; 1984 Jun; 310(24):1566-9. PubMed ID: 6539421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.
    Dilsizian V; Bonow RO; Epstein SE; Fananapazir L
    J Am Coll Cardiol; 1993 Sep; 22(3):796-804. PubMed ID: 8102625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-duration electrocardiographic recording in 33 patients with obstructive cardiomyopathy].
    Baille N; Aliot E; Perrot B; Ethévenot G; Neimann JL; Godenir JP; Gilgenkrantz JM; Faivre G
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):730-7. PubMed ID: 6433835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ventricular arrhythmias in obstructive hypertrophic cardiomyopathy. Continuous electrocardiographic study].
    Bourmayan C; Nouhaud M; Fournier C; Bouajina A; Desnos M; Gay J; Gerbaux A
    Presse Med; 1983 Oct; 12(34):2089-92. PubMed ID: 6226033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms.
    Sung RJ; Tai DY; Svinarich JT
    Am Heart J; 1984 Oct; 108(4 Pt 2):1115-20. PubMed ID: 6148871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
    Singh BN; Jewitt DE
    Drugs; 1974; 7(6):426-61. PubMed ID: 4153572
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
    Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
    Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of arrhythmias during exercise stress testing in patients with hypertrophic cardiomyopathy.
    Drăgulescu SI; Brînzan O; Streian C
    Rom J Intern Med; 1991; 29(1-2):33-7. PubMed ID: 1947710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.
    Kuck KH; Kunze KP; Schlüter M; Nienaber CA; Costard A
    Eur Heart J; 1988 Feb; 9(2):177-85. PubMed ID: 3280318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially lethal arrhythmias and their management in hypertrophic cardiomyopathy.
    Frank MJ; Watkins LO; Prisant LM; Stefadouros MA; Abdulla AM
    Am J Cardiol; 1984 Jun; 53(11):1608-13. PubMed ID: 6539560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.